Optimisation of a dilute-and-shoot UHPLC-MS method for high-throughput urinary metabolomics

INTRODUCTION: Urinary metabolomics using liquid chromatography-mass spectrometry (LC-MS) holds great potential for biomarker discovery and clinical application. Large-scale studies and clinical trials require rapid, scalable methods. However, existing urine extraction and LC-MS approaches lack standardisation and clear recommendations for high-throughput use. OBJECTIVES: To optimise a dilute-and-shoot urinary metabolite extraction and untargeted ultra-high-performance LC-MS (UHPLC-MS) method suitable for large-scale studies, and to demonstrate its performance in a clinical cohort. METHODS: We systematically optimised eight parameters: extraction solvent, dilution factor, chromatographic gradient, injection volume, flow rate, gradient curve factor, full scan automatic gain control (AGC) and MS/MS AGC. Performance was assessed by the number of metabolites detected, peak quality, creatinine performance and peak quality factors (PQFs). The optimised method was applied to 1094 urine samples (862 clinical samples plus QCs) from healthy controls and patients with inflammatory bowel disease (IBD). We compared three normalisation strategies for their effect on data precision: no normalisation, creatinine normalisation and probabilistic quotient normalisation (PQN). RESULTS: The optimised method used a C18 column in positive ionisation mode. The mobile phases were water and acetonitrile, each with 0.1% formic acid (v/v). Data acquisition took 6.5 min, and the total run time was 10 min including a cleaning step. In the IBD cohort, over 1500 metabolites were putatively annotated in 182.3 h of instrument time. This saved over 91 h compared with the previously used method. CONCLUSIONS: This optimised method provides rapid, scalable untargeted urinary metabolomics suitable for large clinical studies and trials.

Authors

Institutions

Publication Details

Journal
Metabolomics
Published
2026-11-13
DOI
https://doi.org/10.1007/s11306-026-02542-1
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Optimisation of a dilute-and-shoot UHPLC-MS method for high-throughput urinary metabolomics

Gillian Farrell, Konstantinos Gerasimidis, Konstantinos Gkikas, Caroline Kerbiriou et al.
Metabolomics
Metabolomics and Mass Spectrometry Studies
article

Optimisation of a dilute-and-shoot UHPLC-MS method for high-throughput urinary metabolomics

Gillian Farrell, Konstantinos Gerasimidis, Konstantinos Gkikas, Caroline Kerbiriou, Nicholas J. W. Rattray, Patricia Kelly, Kelly Stewart, Bernadette White
article en

Abstract

INTRODUCTION: Urinary metabolomics using liquid chromatography-mass spectrometry (LC-MS) holds great potential for biomarker discovery and clinical application. Large-scale studies and clinical trials require rapid, scalable methods. However, existing urine extraction and LC-MS approaches lack standardisation and clear recommendations for high-throughput use. OBJECTIVES: To optimise a dilute-and-shoot urinary metabolite extraction and untargeted ultra-high-performance LC-MS (UHPLC-MS) method suitable for large-scale studies, and to demonstrate its performance in a clinical cohort. METHODS: We systematically optimised eight parameters: extraction solvent, dilution factor, chromatographic gradient, injection volume, flow rate, gradient curve factor, full scan automatic gain control (AGC) and MS/MS AGC. Performance was assessed by the number of metabolites detected, peak quality, creatinine performance and peak quality factors (PQFs). The optimised method was applied to 1094 urine samples (862 clinical samples plus QCs) from healthy controls and patients with inflammatory bowel disease (IBD). We compared three normalisation strategies for their effect on data precision: no normalisation, creatinine normalisation and probabilistic quotient normalisation (PQN). RESULTS: The optimised method used a C18 column in positive ionisation mode. The mobile phases were water and acetonitrile, each with 0.1% formic acid (v/v). Data acquisition took 6.5 min, and the total run time was 10 min including a cleaning step. In the IBD cohort, over 1500 metabolites were putatively annotated in 182.3 h of instrument time. This saved over 91 h compared with the previously used method. CONCLUSIONS: This optimised method provides rapid, scalable untargeted urinary metabolomics suitable for large clinical studies and trials.

MetabolomicsVol. 22(6)
University of Strathclyde (GB), NHS Lanarkshire (GB), University of Glasgow (GB)
Good health and well-being
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon